[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337128-105":59,"doc-detail-337128-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","closing-editorial-colorectal-cancer-a-molecular-genetics-perspective","Closing Editorial: Colorectal Cancer - A Molecular Genetics Perspective","","Closing Editorial summarizes advances in colorectal cancer (CRC) molecular genetics, emphasizing why early-onset CRC in individuals under 50 demands deeper insight into molecular mechanisms and risk factors. It highlights research spanning multi-gene risk models, circulating mRNA and miRNA biomarkers for noninvasive diagnosis, and the clinical relevance of genetic alterations and epigenetic regulation. Consensus molecular subtypes and NF-κB pathway alterations are presented as frameworks for stratified, targeted therapies, while remaining knowledge gaps guide priorities for standardized validation and future model development.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/closing-editorial-colorectal-cancer-a-molecular-genetics-perspective/337128/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/closing-editorial-colorectal-cancer-a-molecular-genetics-perspective/337128.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is early-onset colorectal cancer (EOCRC) highlighted as an urgent concern?","Question",{"text":112,"@type":113},"EOCRC shows a rising prevalence among people under 50, making it particularly concerning despite progress in screening, diagnosis, and treatment. The trend motivates further study of molecular mechanisms and risk factors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What types of biomarkers and models are discussed in the Special Issue?",{"text":117,"@type":113},"The editorial describes multi-gene risk models for prognosis and drug treatment prediction, alongside circulating mRNA and miRNA biomarkers aimed at noninvasive diagnosis. It emphasizes molecular profiling to support more precise and personalized assessment and early detection.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the editorial connect molecular heterogeneity to personalized medicine?",{"text":121,"@type":113},"It explains that consensus molecular subtypes (CMS1–CMS4) reflect gene-expression profiles and can stratify patients for tailored treatment strategies. It also discusses genetic alterations, including NF-κB pathway changes, as promising therapeutic targets.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337128,1790867165,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Editorial  \nClosing Editorial: Colorectal Cancer—A Molecular Genetics Perspective  \nEhsan Gharib 1,2  \nCitation: Gharib, E. Closing Editorial: Colorectal Cancer—A Molecular Genetics Perspective. Int. J. Mol. Sci. 2024, 25, 12604. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms252312604](10.3390/ijms252312604)  \nReceived: 10 November 2024  \nAccepted: 21 November 2024  \nPublished: 24 November 2024  \nCopyright: © 2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Département de Chimie et Biochimie, Université de Moncton, Moncton, NB E1A 3E9, Canada; [ehsangharib55@gmail.com](ehsangharib55@gmail.com)  \n2 Atlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada  \nColorectal cancer (CRC) remains a significant global health challenge, ranking third in incidence and second in mortality among all cancers [1] . Despite advancements in screening, diagnosis, and treatment, the rising prevalence of early-onset colorectal cancer (EOCRC) in individuals under 50 years old is particularly concerning [2,3] . This alarming trend highlights the need for a better understanding of the underlying molecular mechanisms and risk factors associated with EOCRC [4] . Furthermore, the development of more effective screening strategies and targeted interventions for this younger patient population is crucial to improve outcomes and reduce the burden of CRC [5–9] . This Special Issue, titled“Colorectal Cancer: A Molecular Genetics Perspective”, showcases the latest research and developments in understanding the molecular mechanisms underlying CRC and their potential applications in improving patient outcomes. The studies presented here provide valuable insights into the complex genetic and epigenetic landscape of CRC, paving the way for novel diagnostic, prognostic, and therapeutic approaches.  \nThe articles in this Special Issue cover a wide range of topics, varying from the construction of multi-gene risk models for CRC prognosis and drug treatment prediction [10] to the identification of novel circulating mRNA [11] and miRNA biomarkers for noninvasive diagnosis [12] . These studies underscore the potential of leveraging molecular profiling techniques to develop more precise and personalized risk assessment tools and early detection methods. The role of specific genetic alterations, such as KRAS mutations, in CRC-associated thrombosis [13] and therapeutic resistance [14] is also explored, highlighting the importance of understanding the functional consequences of these genetic changes in the context of CRC pathogenesis and treatment. Additionally, the importance of epigenetic regulation, including DNA methylation, histone modifications, and non-coding RNAs, in CRC pathogenesis and their potential as diagnostic and prognostic markers are highlighted [15] . These findings emphasize the need to integrate epigenetic data with genetic information to gain a more comprehensive understanding of CRC biology and identify novel therapeutic targets.  \nSeveral studies in this Special Issue focus on the molecular heterogeneity of CRC and its implications for personalized medicine. The consensus molecular subtypes (CMS1-CMS4) are examined, shedding light on disease heterogeneity and their potential for guiding targeted therapies [16] . These subtypes, based on gene expression profiles, provide a framework for stratifying CRC patients and tailoring treatment strategies based on their molecular characteristics [16,17] . The genetic alterations in the NF-κB signaling pathway, estimated to account for over 50% of the overall genetic changes in CRC patients, are also discussed as promising targets for novel therapeutic development [18] . Given the central","cbCaic4i3OLlLWaS","https://ap.wps.com/l/cbCaic4i3OLlLWaS","pdf",220103,"English","# Closing Editorial: Colorectal Cancer—A Molecular Genetics Perspective\n## Rationale and scope of the Special Issue\n## Molecular profiling for diagnosis, prognosis, and therapy\n## Heterogeneity, molecular subtypes, and signaling targets\n## Remaining gaps and future research directions","[{\"question\":\"Why is early-onset colorectal cancer (EOCRC) highlighted as an urgent concern?\",\"answer\":\"EOCRC shows a rising prevalence among people under 50, making it particularly concerning despite progress in screening, diagnosis, and treatment. The trend motivates further study of molecular mechanisms and risk factors.\"},{\"question\":\"What types of biomarkers and models are discussed in the Special Issue?\",\"answer\":\"The editorial describes multi-gene risk models for prognosis and drug treatment prediction, alongside circulating mRNA and miRNA biomarkers aimed at noninvasive diagnosis. It emphasizes molecular profiling to support more precise and personalized assessment and early detection.\"},{\"question\":\"How does the editorial connect molecular heterogeneity to personalized medicine?\",\"answer\":\"It explains that consensus molecular subtypes (CMS1–CMS4) reflect gene-expression profiles and can stratify patients for tailored treatment strategies. It also discusses genetic alterations, including NF-κB pathway changes, as promising therapeutic targets.\"}]","Closing Editorial: Colorectal Cancer - A Molecular Genetics Perspective | PDF",1790017801,13,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf289f591c3cb99e10466cddb27bca4f.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f13603ceb4c53d43044626f645ea6d4.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62a12ffd5d01191043de4c634b75c3b2.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64219f287d35c073c1b86331178771b2.webp",980,1385]